ZOMZomedica Corp.

NYSE zomedica.com


$ 0.17 $ 0.02 (11.57 %)    

Monday, 06-May-2024 15:59:46 EDT
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 0.162
$ 0.16
$ 0.00 x 0
$ 0.00 x 0
$ 0.16 - $ 0.17
$ 0.12 - $ 0.25
14,655,672
na
158.75M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 02-26-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 02-28-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zomedica-secures-ce-certification-for-vetguardian-expanding-access-to-contactless-monitoring-for-vets-in-the-eu

Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care dia...

 zomedica-q4-2023-gaap-eps-002-sales-7337m-beat-7000m-estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share. The company reported quarterly sales of $7.337 million whi...

 earnings-scheduled-for-april-1-2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

 zomedica-says-continuing-dialogue-with-senior-regulatory-staff-at-nyse-american-regarding-next-steps-to-regaining-compliance-with-its-listing-standards

Zomedica shares will remain listed on the NYSE American at this time. A Special Meeting of Shareholders was held on February 28...

 zomedica-announces-1-for-80-reverse-stock-split

Seeking Approval for 80 - 1 Reverse Stock SplitAs announced on January 10, 2024, the Company will be holding a Special Virtual-...

 zomedica-expands-market-opportunity-for-truforma-diagnostic-platform-with-launch-of-three-new-assays-for-commonly-performed-diagnostic-tests-for-canine-gastrointestinal-disease

News assays include: Canine Pancreatic Lipase (cPL), Cobalamin (B12) and Folate, for the TRUFORMA® In-Clinic Biosensor Testin...

 zomedica-q3-eps-000-up-from-001-yoy-sales-635m-miss-828m-estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.00) per share. This is a 80 percent increase over losses of $(0.01) per sh...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

 zomedica-form4-filing-shows-ceo-larry-c-heaton-bought-100000-shares-at-an-average-price-of-019share

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION